# The Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2003, Regulation 3: Amendment of the Misuse of Drugs Regulations (Northern Ireland) 2002


(1) The Misuse of Drugs Regulations (Northern Ireland) 2002 shall be amended in accordance with paragraphs (2) to (4).
(2) In paragraph 1 of Schedule 2 there shall be inserted –
(a) after “Dihydrocodeinone O-carboxymethyloxime”, “Dihydroetorphine”; and
(b) after “Racemorphan”, “Remifentanil”.
(3) In paragraph 1, of Part I of Schedule 4 there shall be inserted –
(a) after “Haloxazolam”, “4-Hydroxy-n-butyric acid”; and
(b) after “N-Ethylamphetamine”, “Zolpidem”.
(4) In paragraph 1, of Part II of Schedule 4 there shall be inserted –
(a) before “Atamestane”, “4-Androstene-3, 17-dione” and “5-Androstene-3, 17 diol”; and
(b) after “Nandrolene”, “19-Nor-4-Androstene-3, 17 dione” and “19-Nor-5-Androstene-3, 17 diol”.

---
Source: https://www.legislation.gov.uk/nisr/2003/314/regulation/3 (the official version)
Page: https://openlegislation.uk/misuse-of-drugs-amendment-regulations-northern-ireland-2003/regulation-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.